(Total Views: 811)
Posted On: 02/06/2021 12:27:19 AM
Post# of 153908

Re: ClosetInvestor #76609
Quote:
Neither NP nor SK have the education, training, or experience to identify PDL1 as a target for leronlimab.
That's why it's very good we have a Scientific Advisory Board... and me.


